2nd ADC Analytical Development Summit | April 25-27 2023 | Boston, MA

Kongressthemen
As ADCs as a modality see continued clinical progress, drug developers are becoming more creative with their drug design and new analytical technologies are improving the resolution so that you can understand the characteristics of your drug. However, key regulatory questions are arising and agency expectations regarding what needs to be characterized and to what degree, what quality attributes are critical, and what variation is allowed in control processes are at the forefront of mind.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/1485218-3?pid=4832

Speakers: Adrienne Wildt, Senior Director, Analytical Development, ImmunoGen, Aming Zhang, Head of Analytical Development and QC, Pyxis Oncology, and more.

https://go.evvnt.com/1485218-2?pid=4832

Frau Jessica Durston